Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

FDA draft guidance on platelet safety

FDA Draft Guidance, December 2018

Key clinical point: The Food and Drug Administration issued recommendations to control the risk of bacterial contamination of room temperature stored platelets intended for infusion.

Major finding: For apheresis platelets and prestorage pools stored for 5 days, FDA recommended an initial primary culture followed by a secondary culture on day 3 or 4; or an initial primary culture followed by secondary testing with a rapid test. For aspheresis platelets, the agency also recommended using pathogen reduction alone.

Study details: The guidance is based on data presented at a July 2018 meeting of the FDA Blood Products Advisory Committee meeting and the committee’s recommendations.

Disclosures: The draft guidance was issued by officials in the Centers for Biologics Evaluation and Research at the FDA.

Read the article here.

Citation:

FDA draft guidance, December 2018. “Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion.”

https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM627407.pdf

This Week's Must Reads

RNA expression offers potential biomarker in hemophilia A, Niloofar N et al. Hematology. 2019;24(1):255-62

Caplacizumab speeds platelet normalization, Scully M et al. N Engl J Med. 2019 Jan 9. doi: 10.1056/NEJMoa1806311

Remote area of Canada provides pool for genetic research, Scully M-F et al. Transfus Apher Sci. 2018 Dec;57(6):713-6

Can web tools replace pharmacokinetic analysis in hemophilia A?, Nagao A et al. Thromb Res. 2019 Jan;173:79-84

BSH issues recommendations for glucocorticoid use in ITP, Hill QA et al. Br J Haematol. 2019 Jan 4. doi: 10.1111/bjh.15735

Must Reads in Bleeding Disorders

BSH issues recommendations for glucocorticoid use in ITP, Hill QA et al. Br J Haematol. 2019 Jan 4. doi: 10.1111/bjh.15735

RNA expression offers potential biomarker in hemophilia A, Niloofar N et al. Hematology. 2019;24(1):255-62

Caplacizumab speeds platelet normalization, Scully M et al. N Engl J Med. 2019 Jan 9. doi: 10.1056/NEJMoa1806311

Remote area of Canada provides pool for genetic research, Scully M-F et al. Transfus Apher Sci. 2018 Dec;57(6):713-6

Can web tools replace pharmacokinetic analysis in hemophilia A?, Nagao A et al. Thromb Res. 2019 Jan;173:79-84